TWOEquity · Weekly research terminal

4183

EPS Bio Technology Corp.

TW Healthcare Medical Devices

Latest week
14 Aug 2026
Weekly close
14.50 TWD
Fair value
19.70 TWD
Next-week expectancy
Undecided 45.82%
Sharemaestro
Weekly Chart Pack Completed weekly market data · Independent research

TWO · Equity · Taiwan

4183

EPS Bio Technology Corp.

Healthcare Medical Devices

EPS Bio Technology Corp. manufactures and sells OEM/ODM blood glucose system in Taiwan. It also provides test strip; diabetic self-monitoring blood glucose systems under the EASYMAX and MDT2 BLE name; and wearable, and NFC and Bluetooth connectivity blood glucose monitors. The company was founded in 2006 and is headquartered in Hsinchu City, Taiwan.

Last updated
14 Aug 2026
Exchange
Taipei Exchange · TWO
Sector
Healthcare
Industry
Medical Devices
Currency
TWD
Market capitalisation
345,100,000
Fair value reference
19.70
Next-week expectancy
Undecided · 45.82%

Over the latest 12 completed weeks ending 2026-08-14, 4183 rose 11.54%, moving from 13.00 to 14.50. The latest weekly close is below the Trend Line and below Fair Value. Trend Signal is inactive on the latest week and was active in 0 of the last 12 weeks. Relative Strength is -38.05 and has improved across the 12-week window. Market Dynamics is 0.82 on the latest week. Next-week expectancy is undecided at 45.82% based on similar historical setup states.

Week Ending
14 Aug 2026
Latest Close
14.50
12-Week Change
11.54%
Trend Signal
Inactive
Next-Week Expectancy
Undecided 45.82%
Signal Weeks
0 of 12

Weekly Price

Weekly Close Trend Line Fair Value Activity Lines

Chart Panels

Choose up to 5 panels. Drag panel headers to reorder.

Chart Summary

Key Points

Week Ending
14 Aug 2026
Latest Close
14.50
12-Week Change
11.54%
Trend Signal
Inactive
Next-Week Expectancy
Undecided 45.82%
Signal Weeks
0 of 12
Vs Trend Line
Below
Vs Fair Value
Below
Relative Strength
-38.05
Market Dynamics
0.82

Over the latest 12 completed weeks ending 2026-08-14, 4183 rose 11.54%, moving from 13.00 to 14.50. The latest weekly close is below the Trend Line and below Fair Value. Trend Signal is inactive on the latest week and was active in 0 of the last 12 weeks. Relative Strength is -38.05 and has improved across the 12-week window. Market Dynamics is 0.82 on the latest week. Next-week expectancy is undecided at 45.82% based on similar historical setup states.

Industry Peers

Taiwan equities in Medical Devices

Stock Exchange Week Open High Low Close Change
4735 AViTA Corporation TWO 14 Aug 2026 34.00 40.80 33.00 38.15 12.21%
6796 Medimaging Integrated Solution Inc. TAI 14 Aug 2026 55.20 63.00 55.20 60.10 8.88%
4736 TaiDoc Technology Corporation TAI 14 Aug 2026 130.00 142.00 129.00 139.00 6.92%
6918 A Plus Biotechnology Co., Ltd. TAI 14 Aug 2026 70.60 75.10 70.60 74.00 4.82%
6815 Diamond Biotechnology Co., Ltd TWO 14 Aug 2026 24.20 25.00 23.20 24.95 3.10%
7713 WeLeader Biomedical Co., Ltd. TWO 14 Aug 2026 69.00 72.10 68.90 70.80 2.61%
7799 Heron Neutron Medical Corp. TAI 14 Aug 2026 358.00 371.00 347.00 367.00 2.51%
6572 PlexBio Co., Ltd. TWO 14 Aug 2026 7.14 8.20 6.90 7.24 1.40%
4155 OK Biotech Co., Ltd. TAI 14 Aug 2026 14.65 15.30 14.20 14.80 1.02%
6758 A-SPINE Asia Co., Ltd. TWO 14 Aug 2026 28.85 29.25 28.00 29.10 0.87%
4198 S&S Healthcare Holding Ltd. TWO 14 Aug 2026 41.40 42.45 40.00 41.75 0.85%
6767 Wiltrom Co., Ltd. TWO 14 Aug 2026 24.70 24.90 24.50 24.80 0.40%
4106 Wellell Inc. TAI 14 Aug 2026 24.60 25.30 24.30 24.65 0.20%
1788 Hi-Clearance Inc. TWO 14 Aug 2026 130.50 131.00 129.50 130.50 0.00%
3373 Radiant Innovation Inc. TWO 14 Aug 2026 16.65 16.90 16.35 16.65 0.00%
6861 InnoCare Optoelectronics Corporation TAI 14 Aug 2026 215.00 227.50 210.50 215.00 0.00%

Next-week expectancy

Next-week expectancy is a short-term historical read. It compares the latest completed-week setup with broadly similar past setups and asks whether the following week tended to close higher or lower.

It is not a trend call, a price target, or a guarantee. A positive read can appear while price is below trend or activity pressure is weak, because it is measuring short-term follow-through odds for the current setup state.

Use it as one context layer beside Trend Line, Relative Strength, Market Dynamics, Fair Value, and the visible price structure.

Evidence context